Back in 1995 — long before nanotech became a buzzword
Doxil, a chemo drug wrapped in a fatty nanoscale shell, became the first FDA-approved nanomedicine in 1995. The coating helps it circulate longer and reach tumors, so the field is decades older than most people assume.
